We have exmined the effect of a synthetic analogue of human et-atrial natriuretic peptide (ANP), APH, on renin release in cultured renal juxtaglomerular cells (JGA cells). Using cell cultures containing 80-90% renal juxtaglomerular cells, we found that ANP (10-13-10-9 M) strongly inhibited renin release from the cells in a dose-dependent fashion (ki, 10 pM) to about 10% of control. Inhibition of renin release by ANP was paralleled by an increase in cellular cGMP levels; while in the presence of the cGMP-phosphodiesterase inhibitor M&B 22948 (1 mM), concentrations of ANP lower by a factor of 100 were required to obtain the same effects on renin release and cGMP levels. The guanylate cyclase inhibitor methylene blue (10 IAM), on the other hand, shifted the dose-response curves for renin release and cGMP levels to 100-fold higher concentrations of ANP. Neither the influx of 45Ca into the cells nor the intracellular quin-2 signal, which is a measure for changes of intracellular Ca concentration, was in any way altered by ANP. Our results suggest that ANP inhibits renin release from juxtaglomerular cells by a cGMP-dependent process that does not involve changes in intracellular calcium.
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Two major effects of atrial natriuretic peptide (ANP) on renal function have been described, namely the enhancement of sodium and water excretion (cf. refs. 1 and 2) and the suppression of renin release (3) (4) (5) . Inhibition of renin release by ANP leading to a diminished formation of angiotensin II (AI) would result in decreased vascular tone and impaired aldosterone secretion. Both effects are of physiological importance during states of expanded extracellular volume, in which enhanced release of ANP from the atrium is observed (6, 7) .
The mechanism by which ANP inhibits renal renin release is as yet a matter of debate (2) . In view of the increased filtration rate of NaCl caused by the ANP, which leads to an increased NaCl load at the macula densa, it has been speculated that ANP inhibits renin release fromjuxtaglomerular cells via the macula densa receptor (3, 4) . However, a direct effect of ANP on juxtaglomerular cells could not be excluded on the basis of experimental evidence. Therefore, we wanted to investigate whether or not ANP directly inhibits renin release by renal juxtaglomerular cells.
We have developed a cell culture system that contains around 50% juxtaglomerular cells (8, 9) . We now have improved this method by including a Percoll-density gradient in the cell preparation procedure. As a result, cell cultures can be obtained that contain regularly between 80 and 90% juxtaglomerular cells.
We found that ANP strongly inhibits renin release from these cultured cells and, furthermore, obtained strong evidence that the inhibitory effect of ANP is mediated by cGMP and does not involve an increase in intracellular calcium.
MATERIALS AND METHODS
Cell Culture. Isolation ofjuxtaglomerular cells was essentially as described (8, 9 15 ,000 x g in a vertical rotor (SV-288, Sorvall) for 30 min. Four different bands with densities of 1.02 g/ml, 1.05 g/ml, 1.06 g/ml, and 1.13 g/ml were regularly obtained. Table 1 gives typical values for the distribution ofprotein and specific renin activity within the gradient. Band III cells (1.06 g/ml)
were incubated with culture medium [RPMI 1640, 25 mM Hepes, streptomycin at 100 tug/ml, penicillin at 100 units/ml, 2% (vol/vol) fetal bovine serum] at 370C in 5% C02/95% air. All experiments as described below were performed on the second day of culture.
Renin Demonstration by Immunofluorescence. Immunofluorescence staining for renin was done exactly as described (9) . In brief, cell cultures were fixed in 4% (wt/vol) paraformaldehyde/Dulbecco's phosphate-buffered saline (PBS). After 5 min in 10% (vol/vol) normal swine serum/0.1% bovine serum albumin/PBS, the cultures were incubated with rabbit antiserum against rat renin diluted 1:200 in 10% (vol/vol) normal swine serum/PBS. After rinsing in PBS, a 30-min incubation followed with tetramethylrhodamine B isothiocyanate (TRITC)-conjugated goat anti-rabbit IgG (1:500, Sigma). The specificity of the immunoreaction was tested with the usual control procedures (9) . Immunofluorescence was examined using a Polyvar fluorescence microscope (Reichert-Jung, Vienna, Austria). Rabbit antiserum against rat renin, used in the studies, was a generous gift of M. Celio (Zurich) who obtained it from T. Inagami (Nashville, TN). For immunocytochemical demonstration and localization with the protein A/gold technique, pellets of 106 cells were fixed in 1% glutaraldehyde and embedded in London White resin (London Resin, Basingstoke, England). Ultrathin sections were immunostained for renin as described by Taugner et al. (10) . Rabbit antiserum against rat renin used in these studies was a generous gift from E. Hackenthal.
Renin Release. Renin release from the cultured cells was determined exactly as described (8) . In brief, the culture medium was replaced with prewarmed, Hepes-buffered saline [132 mM NaCl, 5 mM KCl, 0.8 mM MgSO4, 2 mM CaCl2, Abbreviations: ANP, atrial natriuretic peptide; Al, angiotensin I;
All, angiotension II; [Ca]j, intracellular Ca2+ concentration.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 10 mM NaOAc, 2 mM NaH2PO4, 10 mM glucose, 20 mM Hepes (pH 7.2)]; and the culture dishes were placed on a heating block at 370C. The renin secretion rate was calculated from the linear increase of the renin activity of the cellconditioned buffer before and 10, 20, and 30 min after addition of the agents.
Renin Activity Assay. Renin activity was determined by its ability to generate angiotensin I (AI) from the plasma of bilaterally nephrectomized rats exactly as described (11) . AI was determined by radioimmunoassay (Isotopen Dienst West, Teufen, Switzerland).
Intracellular cGMP Levels. Intracellular cGMP concentrations were examined under the same experimental conditions as the renin release. Five minutes after the addition of the agents, the buffer was removed from the cultures, and the dishes were placed on an ice block. After the addition of 0.4 ml of ice-cold 5 mM potassium phosphate, 0.2 mM EDTA, 0.5 mM 3-isobutyl-methylxanthine, and 150 mM KCl (pH 6.8), the cells were scraped off with a Teflon policeman. The cell suspension so obtained was sonicated, boiled for 5 min, and centrifuged. An aliquot was removed from the sonicated cell suspension for protein determination. The supernatants were assayed for cGMP using a cGMP radioimmunoassay (New England Nuclear).
45Ca-Uptake. 45Ca-uptake into the cultured cells was determined exactly as described (8 (Fig. 1, Lower) . As we have also shown elsewhere (9) , the round cells that stain for renin contain prominent renin granules (Fig. 2) . We, therefore, conclude that these cells are juxtaglomerular cells. The cellular renin activity of the cultured cells used in this study was between 100-200 ng of Al per hr per mg of protein on the second day of culture. The renin activity in the culture medium was between 1 and 2.6 ,g of AI per hr per mg of cellular protein.
Effect of ANP on the Cultured Cells. Fig. 3 shows the effect of ANP on the spontaneous renin release from the cultured cells. It can be seen that ANP strongly inhibited renin release in a dose-dependent fashion between 10-13 and 10-9 M. In parallel with the inhibition of renin release, ANP led to an increase in intracellular cGMP levels (Fig. 4) . To find out whether or not the inhibitory effect of ANP on renin release is causally linked to the increase in intracellular cGMP, we examined the effects of ANP on renin release and cGMP levels in presence of the cGMP phosphodiesterase inhibitor M&B 22948 (14) and the guanylate cyclase inhibitor methylene blue (15) . Fig. 4 shows that M&B 22948 (1 mM) shifted the dose-response curves for renin release and cGMP levels to concentrations of ANP lower by a factor of 100. Methylene blue (10 ,uM) on the other hand decreased the ANP sensitivity of renin release and cGMP levels ofjuxtaglomerular cells by a factor of 100. Nitroprusside also elevates intracellular cGMP levels by stimulating soluble guanylate cyclase (14, 16) . We, therefore, tested the effect of sodium nitroprusside on renin release and cGMP levels of the cultured juxtaglomerular cells. We found that 1 ,iM sodium nitroprusside decreased renin release to 54 ± 10% of control (n = 5) and elevated cGMP levels to 154 ± 9% of control (n = 5).
Because there is strong evidence that an increase in the intracellular calcium concentration is an inhibitory signal for renin release from juxtaglomerular cells (8, 17, 18 are mean ± SEM of six experiments.
wanted to find out whether or not ANP influences calcium metabolism in cultured juxtaglomerular cells. We, therefore, studied the effect of ANP on the influx of 45Ca2" into cells.
The data shown in Table 2 (3) (4) (5) . Since the mechanism of this inhibitory effect is unclear, the present study examined whether or not ANP acted directly on juxtaglomerular cells and if so which intracellular events mediated the inhibition of renin release.
For our study we used cell cultures containing 80-90%o cells that stained positive for renin ( Fig. 1) and that contained prominent renin granules (Fig. 2) . Sincejuxtaglomerular cells are the only renal cells that have these two characteristics, we infer from our results that the cells we used in the present culture originate from juxtaglomerular cells.
We found that synthetic ANP, identical to human a-ANP (19), strongly inhibited renin release from thejuxtaglomerular cells (Fig. 3) . Half-maximal inhibition could be observed at 10 pM ANP. It is noteworthy in this context that the normal plasma concentration ofANP is around 10 pM in humans and rats (6, 7, 20, 21) .
During volume expansion ANP levels were found to increase up to 0.1 nM (6, 7). It appears, therefore, that the concentration range in which the ANP can be physiologically varied is well within the concentrations at which we observed inhibition of renin release (Fig. 3) . Therefore, ANP is likely to have a physiologically regulatory function on renin release from the kidney. Moreover, it has been shown that halfmaximal inhibition of aldosterone secretion from adrenal cells by ANP is observed at 20 pM ANP (22) . This figure is very close to the results obtained in this study.
We have obtained three pieces of evidence for a causal link between cGMP and inhibition of renin release by ANP. () ANP elevates cGMP levels, and this effect parallels the inhibition of renin release (Fig. 4). (ii) Inhibition of the cGMP-specific phosphodiesterase (by M&B 22948) leads to an apparent increase of the ANP sensitivity ofjuxtaglomerular cells for the inhibition of renin release and increase of cGMP levels. Inhibition of guanylate cyclase by methylene blue on the other hand lowers the ANP sensitivity of juxtaglomerular cells for renin release and increase in cGMP levels (Fig. 3) . (iii) Sodium nitroprusside, which is known to increase cGMP levels in muscle tissues by activating guanylate cyclase (23) , also elevated cGMP levels in the juxtaglomerular cells and simultaneously inhibited renin release. Fig. 6 shows a plot of renin releasing rate vs. intracellular cGMP levels as a function of ANP in the absence and presence of M&B 22948, methylene blue, and sodium 
